SCHEMBL2025874

SCHEMBL2025874

CN(c1cc(-c2ncc([C@@](C)(Cc3ccccc3)N(C(=O)O)C(C)(C)C)o2)cc(Cl)n1)S(C)(=O)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 10/20 0.42
BACE2 Q9Y5Z0 1/20 0.34
PTPN22 Q9Y2R2 1/20 0.33
CDC7 O00311 1/20 0.33
ROCK2 O75116 1/20 0.33
PIM1 P11309 1/20 0.33
PRKACA P17612 1/20 0.33
CDK2 P24941 1/20 0.33
GSK3B P49841 1/20 0.33
HIPK2 Q9H2X6 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.33
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
ALDH1A1 P00352 1/20 0.31
PTGS2 P35354 1/20 0.31
PTK2 Q05397 1/20 0.30
PPARG P37231 1/20 0.30
PPARD Q03181 1/20 0.30
PPARA Q07869 1/20 0.30
TRPM8 Q7Z2W7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2027658 1.00 BACE1 (0.42) BACE1BACE2PTPN22CDC7ROCK2
SCHEMBL2023115 0.87 BACE1 (0.49) BACE1BACE2CDC7ROCK2PIM1
SCHEMBL2023116 0.87 BACE1 (0.49) BACE1BACE2CDC7ROCK2PIM1
SCHEMBL4945797 0.84 BACE1 (0.44) BACE1BACE2PTPN22CDC7ROCK2
SCHEMBL4947307 0.84 BACE1 (0.44) BACE1BACE2PTPN22CDC7ROCK2
SCHEMBL12578541 0.81 BACE1 (0.42) BACE1BACE2MEN1KMT2AALDH1A1
SCHEMBL2024046 0.81 BACE1 (0.41) BACE1BACE2
SCHEMBL2027660 0.75 BACE1 (0.36) BACE1BACE2
SCHEMBL2025875 0.75 BACE1 (0.39) BACE1BACE2
SCHEMBL4939179 0.75 BACE1 (0.49) BACE1BACE2PTGS2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968571-B2 2,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's Disease Merck, Sharp & Dohme, Corp. (US) 2011-06-28 US disclosed